BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26132412)

  • 1. Synergy Potential of Indole Alkaloids and Its Derivative against Drug-resistant Escherichia coli.
    Dwivedi GR; Gupta S; Maurya A; Tripathi S; Sharma A; Darokar MP; Srivastava SK
    Chem Biol Drug Des; 2015 Dec; 86(6):1471-81. PubMed ID: 26132412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.
    Dwivedi GR; Maurya A; Yadav DK; Khan F; Darokar MP; Srivastava SK
    Chem Biol Drug Des; 2015 Sep; 86(3):272-83. PubMed ID: 25476148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytol derivatives as drug resistance reversal agents.
    Upadhyay HC; Dwivedi GR; Roy S; Sharma A; Darokar MP; Srivastava SK
    ChemMedChem; 2014 Aug; 9(8):1860-8. PubMed ID: 24891085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli.
    Maurya A; Dwivedi GR; Darokar MP; Srivastava SK
    Chem Biol Drug Des; 2013 Apr; 81(4):484-90. PubMed ID: 23290001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of clavine alkaloid 'chanoclavine' with tetracycline against multi-drug-resistant E. coli.
    Dwivedi GR; Maurya A; Yadav DK; Singh V; Khan F; Gupta MK; Singh M; Darokar MP; Srivastava SK
    J Biomol Struct Dyn; 2019 Mar; 37(5):1307-1325. PubMed ID: 29595093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.
    Dwivedi GR; Tiwari N; Singh A; Kumar A; Roy S; Negi AS; Pal A; Chanda D; Sharma A; Darokar MP
    Appl Microbiol Biotechnol; 2016 Mar; 100(5):2311-25. PubMed ID: 26658982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli.
    Dwivedi GR; Upadhyay HC; Yadav DK; Singh V; Srivastava SK; Khan F; Darmwal NS; Darokar MP
    Chem Biol Drug Des; 2014 Apr; 83(4):482-92. PubMed ID: 24267788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial evaluation of hamacanthin B analogues.
    Kim A; Kim MJ; Noh TH; Hong J; Liu Y; Wei X; Jung JH
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5013-5017. PubMed ID: 27614413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & Niazirin.
    Dwivedi GR; Maurya A; Yadav DK; Khan F; Gupta MK; Gupta P; Darokar MP; Srivastava SK
    Curr Top Med Chem; 2019; 19(10):847-860. PubMed ID: 30977451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.
    Caspar Y; Jeanty M; Blu J; Burchak O; Le Pihive E; Maigre L; Schneider D; Jolivalt C; Paris JM; Hequet A; Minassian F; Denis JN; Maurin M
    J Antimicrob Chemother; 2015; 70(6):1727-37. PubMed ID: 25691323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux pump activity in fluoroquinolone and tetracycline resistant Salmonella and E. coli implicated in reduced susceptibility to household antimicrobial cleaning agents.
    Thorrold CA; Letsoalo ME; Dusé AG; Marais E
    Int J Food Microbiol; 2007 Feb; 113(3):315-20. PubMed ID: 17126442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
    Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
    J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cristatumins A-D, new indole alkaloids from the marine-derived endophytic fungus Eurotium cristatum EN-220.
    Du FY; Li XM; Li CS; Shang Z; Wang BG
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4650-3. PubMed ID: 22727636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and drug resistance reversal potential of novel curcumin mimics Van D: Synergy potential of curcumin mimics.
    Raj Dwivedi G; Khwaja S; Singh Negi A; Panda SS; Swaroop Sanket A; Pati S; Chand Gupta A; Bawankule DU; Chanda D; Kant R; Darokar MP
    Bioorg Chem; 2021 Jan; 106():104454. PubMed ID: 33213895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline improved the efficiency of other antimicrobials against Gram-negative multidrug-resistant bacteria.
    Mawabo IK; Noumedem JA; Kuiate JR; Kuete V
    J Infect Public Health; 2015; 8(3):226-33. PubMed ID: 25458915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.